| Gene symbol | BIRC5 | Synonyms | API4, EPR-1 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | baculoviral IAP repeat containing 5 | ||||
| Gene symbol | CTAG1B | Synonyms | CT6.1, CTAG, CTAG1, ESO1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| Gene symbol | MAGEC1 | Synonyms | CT7, CT7.1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq27.2 | dbXrefs | |
| Description | MAGE family member C1 | ||||
| Gene symbol | MAGEC2 | Synonyms | CT10, HCA587, MAGEE1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq27.2 | dbXrefs | |
| Description | MAGE family member C2 | ||||
| Gene symbol | TPBG | Synonyms | 5T4, 5T4AG, M6P1, WAIF1 | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6q14.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | trophoblast glycoprotein | ||||
| GTO ID | GTC1321 |
| Trial ID | NCT00923312 |
| Disease | Lung Non-Small Cell Carcinoma |
| Altered gene | CTAG1B|MAGE-C1|MAGE-C2|BIRC5|TPBG |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | CV9201 |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Safety and Efficacy Phase I/IIa Trial of an RNActive-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) |
| Year | 2009 |
| Country | Germany|Switzerland |
| Company sponsor | CureVac |
| Other ID(s) | CV-9201-003 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||